FORM 4
[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).         
 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
                                                                                  
 OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response... 0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

Mikulinsky Oleg		 2. Issuer Name and Ticker or Trading Symbol

CRYO CELL INTERNATIONAL INC [ CCEL ] 		5. Relationship of Reporting Person(s) to Issuer (Check all applicable)

_____ Director                    _____ 10% Owner
__X__ Officer (give title below)    _____ Other (specify below)
Chief Information Officer
(Last)          (First)          (Middle)

700 BROOKER CREEK BLVD, SUITE 1800		 3. Date of Earliest Transaction (MM/DD/YYYY)

8/25/2022
(Street)

OLDSMAR, FL 34677
(City)        (State)        (Zip)
4. If Amendment, Date Original Filed (MM/DD/YYYY)

 
 6. Individual or Joint/Group Filing (Check Applicable Line)

_X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3) 		2. Trans. Date 2A. Deemed Execution Date, if any 3. Trans. Code
(Instr. 8) 		4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5) 		5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4) 		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 8/25/2022  M  20000 A$3.20 84349 D  

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 3)		2. Conversion or Exercise Price of Derivative Security3. Trans. Date3A. Deemed Execution Date, if any4. Trans. Code
(Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4)		8. Price of Derivative Security
(Instr. 5)		9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4)11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Stock Option $3.20 8/25/2022  M   20000    4/18/2016 4/18/2026 Common Stock 20000 $3.20 10000 D  
Stock Option $7.49           5/21/2018 5/21/2028 Common Stock 8000  8000 D  
Stock Option $7.13           9/4/2019 (1)9/4/2029 Common Stock 4444  4444 D  
Stock Option $6.55           2/27/2020 (2)2/27/2030 Common Stock 1333  1333 D  
Stock Option $8.00           9/23/2021 (3)9/23/2028 Common Stock 10000  10000 D  
Stock Option $11.90           12/28/2021 (4)12/2/2028 Common Stock 20000  20000 D  
Explanation of Responses:
(1) Stock options will vest 1/3 on the date of grant, 1/3 on December 1, 2019 and 1/3 on December 1, 2020.
(2) Stock options will vest 1/3 on the date of grant, 1/3 on December 1, 2020 and 1/3 on December 1, 2021.
(3) Stock options vest at a rate of 1/5 per year commencing on September 23, 2021.
(4) Stock options vest immediately if the price of the Company's stock reaches $25.00 per share during the seven-year option term.

Reporting Owners
Reporting Owner Name / Address
Relationships
Director10% OwnerOfficerOther
Mikulinsky Oleg
700 BROOKER CREEK BLVD
SUITE 1800
OLDSMAR, FL 34677

Chief Information Officer
Signatures
/s/ Oleg Mikulinsky8/29/2022
**Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
*If the form is filed by more than one reporting person, see Instruction 4(b)(v).
**Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note:File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.
Cryo Cell (NASDAQ:CCEL)
Historical Stock Chart
From Oct 2024 to Nov 2024 Click Here for more Cryo Cell Charts.
Cryo Cell (NASDAQ:CCEL)
Historical Stock Chart
From Nov 2023 to Nov 2024 Click Here for more Cryo Cell Charts.